AMACR and clear cell adenocarcinoma: In females, this differential diagnosis is expanded to clear-cell carcinoma of the female genital (napsin A, WT1 and PR positive) tract and in males with clear-cell renal-type prostatic acinar adenocarcinoma (AMACR- and NKX3.1-positive) [11,13,14].